Martin D Hoffman1, Robert H Weiss. 1. *Department of Physical Medicine and Rehabilitation, Department of Veterans Affairs, Northern California Health Care System, and University of California Davis Medical Center, Sacramento, CA; and †Department of Medicine, Department of Veterans Affairs, Northern California Health Care System, and Division of Nephrology, Department of Internal Medicine, University of California Davis Medical Center, Sacramento, CA.
Abstract
OBJECTIVE: Examine whether the acute kidney injury (AKI) commonly observed among ultramarathon participants places the individual at risk for subsequent AKI of worse magnitude. DESIGN: Observational. SETTING: Western States Endurance Run. PARTICIPANTS: Race finishers with postrace blood studies. INDEPENDENT VARIABLE: Acute kidney injury after 1 race. MAIN OUTCOME MEASURES: Extent of AKI in subsequent race. RESULTS: Among 627 finishes in which serum creatinine values were known, 36.2% met "risk" or "injury" criterion with this group characterized by having faster finish times, greater body weight loss during the race, and higher postrace serum creatine kinase and urea nitrogen concentrations when compared with those not meeting the criteria. We identified 38 runners who had undergone postrace blood analyses at multiple races among which 16 (42.1%) met the risk or injury criterion at the first race. Of those 16 runners, 12 (75%) met the criteria at a subsequent race, an incidence that was higher (P = 0.0026) than the overall 36.2% incidence. For most (56.2%) of the 16 runners meeting the criteria at the first race, the subsequent race caused less increase in serum creatinine concentration and decrement in estimated glomerular filtration rate than the first race. CONCLUSIONS: Mild AKI is common in 161-km ultramarathons, but there was no evidence that previous AKI caused greater renal dysfunction from a subsequent exercise stimulus of similar magnitude. This offers some reassurance to runners and their physicians that mild to moderate AKI in the setting of an ultramarathon is not cumulative or without complete recovery of kidney function when stressed.
OBJECTIVE: Examine whether the acute kidney injury (AKI) commonly observed among ultramarathon participants places the individual at risk for subsequent AKI of worse magnitude. DESIGN: Observational. SETTING: Western States Endurance Run. PARTICIPANTS: Race finishers with postrace blood studies. INDEPENDENT VARIABLE: Acute kidney injury after 1 race. MAIN OUTCOME MEASURES: Extent of AKI in subsequent race. RESULTS: Among 627 finishes in which serum creatinine values were known, 36.2% met "risk" or "injury" criterion with this group characterized by having faster finish times, greater body weight loss during the race, and higher postrace serum creatine kinase and urea nitrogen concentrations when compared with those not meeting the criteria. We identified 38 runners who had undergone postrace blood analyses at multiple races among which 16 (42.1%) met the risk or injury criterion at the first race. Of those 16 runners, 12 (75%) met the criteria at a subsequent race, an incidence that was higher (P = 0.0026) than the overall 36.2% incidence. For most (56.2%) of the 16 runners meeting the criteria at the first race, the subsequent race caused less increase in serum creatinine concentration and decrement in estimated glomerular filtration rate than the first race. CONCLUSIONS: Mild AKI is common in 161-km ultramarathons, but there was no evidence that previous AKI caused greater renal dysfunction from a subsequent exercise stimulus of similar magnitude. This offers some reassurance to runners and their physicians that mild to moderate AKI in the setting of an ultramarathon is not cumulative or without complete recovery of kidney function when stressed.
Authors: Martin D Hoffman; Kristin J Stuempfle; Ian R Rogers; Louise B Weschler; Tamara Hew-Butler Journal: Int J Sports Physiol Perform Date: 2011-08-30 Impact factor: 4.010
Authors: Jessica Rose Bruso; Martin D Hoffman; Ian R Rogers; Linda Lee; Gary Towle; Tamara Hew-Butler Journal: Wilderness Environ Med Date: 2010-06-25 Impact factor: 1.518
Authors: Brad L Bennett; Tamara Hew-Butler; Martin D Hoffman; Ian R Rogers; Mitchell H Rosner Journal: Wilderness Environ Med Date: 2014-12 Impact factor: 1.518
Authors: Johannes Burtscher; Paul-Emmanuel Vanderriele; Matthieu Legrand; Hans-Georg Predel; Josef Niebauer; James H O'Keefe; Grégoire P Millet; Martin Burtscher Journal: Sports Med Date: 2022-07-18 Impact factor: 11.928
Authors: Volker Scheer; Nicholas B Tiller; Stéphane Doutreleau; Morteza Khodaee; Beat Knechtle; Andrew Pasternak; Daniel Rojas-Valverde Journal: Sports Med Date: 2021-09-20 Impact factor: 11.928
Authors: Rodrigo Assunção Oliveira; Ana Paula Rennó Sierra; Marino Benetti; Nabil Ghorayeb; Carlos A Sierra; Maria Augusta Peduti Dal Molin Kiss; Maria Fernanda Cury-Boaventura Journal: Oxid Med Cell Longev Date: 2017-12-21 Impact factor: 6.543
Authors: Khrystyna O Semen; Antje R Weseler; Marcel J W Janssen; Marie-José Drittij-Reijnders; Jos L M L le Noble; Aalt Bast Journal: Nutrients Date: 2020-06-01 Impact factor: 5.717
Authors: Daniela Chlíbková; Pantelis T Nikolaidis; Thomas Rosemann; Beat Knechtle; Josef Bednář Journal: Front Physiol Date: 2018-02-12 Impact factor: 4.566
Authors: Whitley C Atkins; Cory L Butts; Melani R Kelly; Chris Troyanos; R Mark Laursen; Andrew Duckett; Dawn M Emerson; Megan E Rosa-Caldwell; Brendon P McDermott Journal: Front Physiol Date: 2022-01-03 Impact factor: 4.566